Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Mantle cell lymphoma presenting as multiple lymphomatous polyposis of the gastrointestinal tract.

Martins C, Teixeira C, Gamito É, Oliveira AP.

Rev Bras Hematol Hemoter. 2017 Jan - Mar;39(1):73-76. doi: 10.1016/j.bjhh.2016.11.005. Epub 2016 Dec 31. No abstract available.

2.

Ball valve syndrome caused by a giant gastric Vanek's tumor.

Martins CR, Gamito É, Oliveira AP.

Rev Esp Enferm Dig. 2017 Mar;109(3):237-238. doi: 10.17235/reed.2017.4526/2016.

3.

Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge.

Martins C, Teixeira C, Ribeiro S, Trabulo D, Cardoso C, Mangualde J, Freire R, Alves AL, Gamito É, Cremers I, Oliveira AP.

Case Rep Gastrointest Med. 2016;2016:6392028. Epub 2016 Oct 10.

4.

Systemic mastocytosis: A rare cause of non-cirrhotic portal hypertension.

Martins C, Teixeira C, Ribeiro S, Trabulo D, Cardoso C, Mangualde J, Freire R, Gamito É, Alves AL, Cremers I, Alves C, Neves A, Oliveira AP.

World J Gastroenterol. 2016 Jul 28;22(28):6559-64. doi: 10.3748/wjg.v22.i28.6559.

5.

Metabolic syndrome and colorectal neoplasms: An ominous association.

Trabulo D, Ribeiro S, Martins C, Teixeira C, Cardoso C, Mangualde J, Freire R, Gamito É, Alves AL, Augusto F, Oliveira AP, Cremers I.

World J Gastroenterol. 2015 May 7;21(17):5320-7. doi: 10.3748/wjg.v21.i17.5320.

6.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team.

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

7.

[Malignant peritoneal mesothelioma].

Cardoso C, Gamito E, Quintana C, Oliveira AP.

Acta Med Port. 2011 Dec;24 Suppl 3:689-94. Epub 2011 Dec 31. Review. Portuguese.

8.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team.

N Engl J Med. 2012 Jun 21;366(25):2345-57. doi: 10.1056/NEJMoa1114635. Epub 2012 May 21.

9.

Appropriateness of outpatient gastrointestinal endoscopy in a non-academic hospital.

Mangualde J, Cremers MI, Vieira AM, Freire R, Gamito E, Lobato C, Alves AL, Augusto F, Oliveira AP.

World J Gastrointest Endosc. 2011 Oct 16;3(10):195-200. doi: 10.4253/wjge.v3.i10.195.

10.

The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer.

Barqawi AB, Turcanu R, Gamito EJ, Lucia SM, O'Donnell CI, Crawford ED, La Rosa DD, La Rosa FG.

Int J Clin Exp Pathol. 2011 Jun 20;4(5):468-75. Epub 2011 Jun 12.

11.

Reduced lung-cancer mortality with low-dose computed tomographic screening.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD.

N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.

12.

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

JAMA. 2011 Jun 8;305(22):2295-303. doi: 10.1001/jama.2011.766.

PMID:
21642681
13.

The National Lung Screening Trial: overview and study design.

National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ.

Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808. Epub 2010 Nov 2.

14.

Native American breast cancer survivors' physical conditions and quality of life.

Burhansstipanov L, Krebs LU, Seals BF, Bradley AA, Kaur JS, Iron P, Dignan MB, Thiel C, Gamito E.

Cancer. 2010 Mar 15;116(6):1560-71. doi: 10.1002/cncr.24924.

15.

A comparative study of two methods of colonic cleansing before colonoscopy.

Cremers MI, Mangualde J, Vieira AM, Freire R, Gamito E, Lobato C, Alves AL, Augusto F, Oliveira AP.

Hepatogastroenterology. 2009 Jul-Aug;56(93):989-91.

PMID:
19760926
16.

Mortality results from a randomized prostate-cancer screening trial.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797.

17.

Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Gren L, Broski K, Childs J, Cordes J, Engelhard D, Gahagan B, Gamito E, Gardner V, Geisser M, Higgins D, Jenkins V, Lamerato L, Lappe K, Lowery H, McGuire C, Miedzinski M, Ogden S, Tenorio S, Watt G, Wohlers B, Marcus P.

Clin Trials. 2009 Feb;6(1):52-9. doi: 10.1177/1740774508100974.

18.

Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Pinsky PF, Ford M, Gamito E, Higgins D, Jenkins V, Lamerato L, Tenorio S, Marcus PM, Gohagan JK.

J Natl Med Assoc. 2008 Mar;100(3):291-8.

PMID:
18390022
19.

The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions.

Serkova NJ, Gamito EJ, Jones RH, O'Donnell C, Brown JL, Green S, Sullivan H, Hedlund T, Crawford ED.

Prostate. 2008 May 1;68(6):620-8. doi: 10.1002/pros.20727.

PMID:
18213632
20.

Prostate cancer: risk assessment and diagnostic approaches.

Gomella LG, Labrie F, Gamito EJ, Brawer MK.

Rev Urol. 2001;3 Suppl 2:S31-8.

Supplemental Content

Loading ...
Support Center